Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety

Neuropharmacology

Volumn 53, Issue 5, 2007, Pages 609-618

  Munro, Gordon ^a   Erichsen, Helle K ^a   Mirza, Naheed R ^a  

^a NEUROSEARCH A S   (Denmark)

Author keywords

Antiepileptic; Conditioned fear; Formalin test; Gabapentin; Lamotrigine; Levetiracetam; Pain affect; Retigabine; Riluzole; Voltage activated Na+ channel

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FORMALDEHYDE; GABAPENTIN; GI 267119X; LAMOTRIGINE; PHENYTOIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; POTASSIUM CHANNEL KV7; RETIGABINE; RILUZOLE; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EMOTION; MALE; NERVE CELL EXCITABILITY; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SENSORY STIMULATION; SYMPTOMATOLOGY; TRANQUILIZING ACTIVITY;

ANALGESICS; ANIMALS; ANTICONVULSANTS; ANXIETY; CHRONIC DISEASE; CONDITIONING, OPERANT; ELECTROSHOCK; EMOTIONS; EXPLORATORY BEHAVIOR; FORMALDEHYDE; MALE; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34848923432     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.07.002     Document Type: Article

References (45)

1. Ardid D., Lamberty Y., Alloui A., Coudore-Civiale M.A., Klitgaard H., and Eschalier A. Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats. European Journal of Pharmacology 473 (2003) 27-33
2. Ballard T.M., Woolley M.L., Prinssen E., Huwyler J., Porter R., and Spooren W. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacology 179 (2005) 218-229
3. Barton M.E., Eberle E.L., and Shannon H.E. The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. European Journal of Pharmacology 521 (2005) 79-85
4. Bayer K., Ahmadi S., and Zeilhofer H.U. Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology 46 (2004) 743-749
5. Blackburn-Munro G. Pain-like behaviours in animals - how human are they?. Trends in Pharmacological Sciences 25 (2004) 299-305
6. Blackburn-Munro G., and Blackburn-Munro R.E. Chronic pain, chronic stress and depression: coincidence or consequence?. Journal of Neuroendocrinology 13 (2001) 1009-1023
7. Blackburn-Munro G., and Erichsen H.K. Antiepileptics and the treatment of neuropathic pain: evidence from animal models. Current Pharmaceutical Design 11 (2005) 2961-2976
8. + channel blockers in the formalin test. European Journal of Pharmacology 445 (2002) 225-232
9. Blackburn-Munro G., Dalby-Brown W., Mirza N.R., Mikkelsen J.D., and Blackburn-Munro R.E. Retigabine: chemical synthesis to clinical application. CNS Drug Reviews 11 (2005) 1-20
10. Clare J.J., Tate S.N., Nobbs M., and Romanos M.A. Voltage-gated sodium channels as therapeutic targets. Drug Discovery Today 5 (2000) 506-520
11. Coderre T.J., Katz J., Vaccarino A.L., and Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 (1993) 259-285
12. Davis M. Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect. Pharmacology & Therapeutics 47 (1990) 147-165
13. A receptors in mediating the anxiolytic effects of benzodiazepines. Journal of Neuroscience 25 (2005) 10682-10688
14. de-Paris F., Busnello J.V., Vianna M.R., Salgueiro J.B., Quevedo J., Izquierdo I., and Kapczinski F. The anticonvulsant compound gabapentin possesses anxiolytic but not amnesic effects in rats. Behavioural Pharmacology 11 (2000) 169-173
15. Dost R., Rostock A., and Rundfeldt C. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn Schmiedeberg's Archives of Pharmacology 369 (2004) 382-390
16. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., Bushnell M.C., Farrar J.T., Galer B.S., Haythornthwaite J.A., Hewitt D.J., Loeser J.D., Max M.B., Saltarelli M., Schmader K.E., Stein C., Thompson D., Turk D.C., Wallace M.S., Watkins L.R., and Weinstein S.M. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Archives of Neurology 60 (2003) 1524-1534
17. Field M.J., Cox P.J., Stott E., Melrose H., Offord J., Su T.Z., Bramwell S., Corradini L., England S., Winks J., Kinloch R.A., Hendrich J., Dolphin A.C., Webb T., and Williams D. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proceedings of the National Academy of Sciences USA 103 (2006) 17537-17542
18. Franklin K.B., and Abbott F.V. Pentobarbital, diazepam, and ethanol abolish the interphase diminution of pain in the formalin test: evidence for pain modulation by GABAA receptors. Pharmacology Biochemistry and Behaviour 46 (1993) 661-666
19. Gilron I., Watson C.P., Cahill C.M., and Moulin D.E. Neuropathic pain: a practical guide for the clinician. CMAJ 175 (2006) 265-275
20. Gower A.J., Falter U., and Lamberty Y. Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat. European Journal of Pharmacology 481 (2003) 67-74
21. Hasnie F.S., Breuer J., Parker S., Wallace V., Blackbeard J., Lever I., Kinchington P.R., Dickenson A.H., Pheby T., and Rice A.S. Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 144 (2007) 1495-1508
22. Henry J.L., Yashpal K., Pitcher G.M., and Coderre T.J. Physiological evidence that the 'interphase' in the formalin test is due to active inhibition. Pain 82 (1999) 57-63
23. Hunt S.P., and Mantyh P.W. The molecular dynamics of pain control. Nature Reviews Neuroscience 2 (2001) 83-91
24. Kaneko M., and Hammond D.L. Role of spinal gamma-aminobutyric acidA receptors in formalin-induced nociception in the rat. Journal of Pharmacology and Experimental Therapeutics 282 (1997) 928-938
25. Korsgaard M.P., Hartz B.P., Brown W.D., Ahring P.K., Strobaek D., and Mirza N.R. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. Journal of Pharmacology and Experimental Therapeutics 314 (2005) 282-292
26. Kuo C.C., Chen R.S., Lu L., and Chen R.C. Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications. Molecular Pharmacology 51 (1997) 1077-1083
27. LaBuda C.J., and Fuchs P.N. Morphine and gabapentin decrease mechanical hyperalgesia and escape/avoidance behavior in a rat model of neuropathic pain. Neuroscience Letters 290 (2000) 137-140
28. LaBuda C.J., and Fuchs P.N. A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats. Experimental Neurology 163 (2000) 490-494
29. Lamberty Y., Falter U., Gower A.J., and Klitgaard H. Anxiolytic profile of the antiepileptic drug levetiracetam in the Vogel conflict test in the rat. European Journal of Pharmacology 469 (2003) 97-102
30. Laughlin T.M., Tram K.V., Wilcox G.L., and Birnbaum A.K. Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. Journal of Pharmacology and Experimental Therapeutics 302 (2002) 1168-1175
31. Lukyanetz E.A., Shkryl V.M., and Kostyuk P.G. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43 (2002) 9-18
32. Luo Z.D., Calcutt N.A., Higuera E.S., Valder C.R., Song Y.H., Svensson C.I., and Myers R.R. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. Journal of Pharmacology and Experimental Therapeutics 303 (2002) 1199-1205
33. Matthews E.A., and Dickenson A.H. Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats. European Journal of Pharmacology 415 (2001) 141-149
34. Mirza N.R., Bright J.L., Stanhope K.J., Wyatt A., and Harrington N.R. Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels?. Psychopharmacology 180 (2005) 159-168
35. Narita M., Kaneko C., Miyoshi K., Nagumo Y., Kuzumaki N., Nakajima M., Nanjo K., Matsuzawa K., Yamazaki M., and Suzuki T. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31 (2006) 739-750
36. Niespodziany I., Klitgaard H., and Margineanu D.G. Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neuroscience Letters 306 (2001) 5-8
37. Otto M., Bach F.W., Jensen T.S., and Sindrup S.H. Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology 62 (2004) 285-288
38. Passmore G.M., Selyanko A.A., Mistry M., Al-Qatari M., Marsh S.J., Matthews E.A., Dickenson A.H., Brown T.A., Burbidge S.A., Main M., and Brown D.A. KCNQ/M currents in sensory neurons: significance for pain therapy. Journal of Neuroscience 23 (2003) 7227-7236
39. Pedersen L.H., and Blackburn-Munro G. Pharmacological characterisation of place escape/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain. Psychopharmacology 185 (2006) 208-217
40. Shannon H.E., Eberle E.L., and Peters S.C. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neuropharmacology 48 (2005) 1012-1020
41. Singh L., Field M.J., Ferris P., Hunter J.C., Oles R.J., Williams R.G., and Woodruff G.N. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology 127 (1996) 1-9
42. Stanhope K.J., and Dourish C.T. Effects of 5-HT1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat. Psychopharmacology 128 (1996) 293-303
43. Sutton K.G., Martin D.J., Pinnock R.D., Lee K., and Scott R.H. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. British Journal of Pharmacology 135 (2002) 257-265
44. Yaksh T.L., Ozaki G., McCumber D., Rathbun M., Svensson C., Malkmus S., and Yaksh M.C. An automated flinch detecting system for use in the formalin nociceptive bioassay. Journal of Applied Physiology 90 (2001) 2386-2402
45. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110